Navigation Links
MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy

safety profile. The most frequently observed sedation-related adverse event in this study was transient hypotension (3%). No adverse events led to procedure or study drug discontinuation.

About Aquavan(R) (fospropofol disodium) Injection

Aquavan(R) (fospropofol disodium) Injection, a proprietary water-soluble prodrug of propofol that after intravenous injection is rapidly converted by an enzyme (alkaline phosphatase) in the body into propofol, is a product candidate in development for sedation of patients undergoing short surgical or diagnostic procedures. Aquavan has not been approved for marketing by the U.S. Food and Drug Administration (U.S. FDA) or any other regulatory agencies.

About MGI PHARMA

MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and acute care that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) Injection, Dacogen(R) (decitabine) for Injection, and Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information about MGI PHARMA, please visit www.mgipharma.com.

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of MGI PHARMA's future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements. Factors that might cause MGI PHARMA's results to differ materially from those expressed or implied by such forward-looking statements include, bu
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:11/25/2009)..., , BEDFORD, Mass., Nov. 25 /PRNewswire-...y) (Nasdaq: HOLX ), a leading developer, manufact...imaging systems and surgical products dedicated to...he annual meeting of the Radiological Society of N... November 29 through December 3, 2009 to highlight...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsRese... : Stelara report,thefirstinamulti-phasesyndica...rOrtho-Biotech,sStelara,fromproductlaunchthroughth...rovidesquantitativeinformationfrom75uniqueDermatol...reportsassesstrialanduseofStelara,obstaclestouse,t...
(Date:11/25/2009)..., RANCHOCORDOVA,Calif.,Nov.25/PRNewswire/--AM...ficCorporation(Nasdaq: APFC )announcedtodaythatitr...lityAwardattheAnnualStatewideEnvironmentalSummit,s...ssociation(CMTA),theIndustrialEnvironmentalAssocia...(CICC)heldinSanDiego.Thisisthemostprestigiousaward...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2New Evidence Shakes Up Perceptions of Salt 59492 1New Evidence Shakes Up Perceptions of Salt 59492 2New Evidence Shakes Up Perceptions of Salt 59492 3New Evidence Shakes Up Perceptions of Salt 59492 4Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients 10363 1Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients 10363 2Beckman Coulter Announces Third Quarter 2009 Earnings to be Released on Thursday October 29 2009 After Market Closes 59491 1
...S, Mich., Jan. 8 CSG/SportsCoatings,today announc...ic turf will,be treated with its industry-leading ...from 1.5 million square feet in 2007., The expone...ributed to,several factors, including a 2007 repor...on that found MRSA (methicillin-resistant Staphlyc...
...s Very Low Dose Glucagon ahead of Phase 2 Clinical... SAN FRANCISCO, Jan. 8 DiObex, Inc., a privately ...or metabolic diseases,announced today that it has ... Trademark Office for the use of very low dose glu...duced hypoglycemia in diabetes patients. The,paten...
Other Medicine Technology:10 Million Square Feet of Turf Set to be Treated in 2008 in Response to MRSA Outbreaks Nationwide 2DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia 2
(Date:11/27/2009)... Multi-purpose bilingual coloring books desi...y the business community to educate - inform paren...m Safety issues to Dinosuars to ABC,S and a host o...ouis, MO (PRWEB) November 27, 2009 -- Today’...s to keep them busy any hour of the day, but one o...
(Date:11/26/2009)...ETON, N.J., Nov. 27 The diabetes p...over the next 25 years and annual medical spending...up from $113 billion today, according to a study p... The National Changing Diabetes ® Program (... analysis by a team from the University of Chicago...
(Date:11/26/2009)...hrill when on an emotional rollercoaster, study fi...s) -- Call it the fear factor meets the jubilant s...rs -- especially those who root for the winning te...osely contested match and victory was in doubt, pr...hew on that this Thanksgiving weekend as you,re gl...
(Date:11/26/2009)... Benton Communications announces a highly ef...for retailers struggling to make an economic recov...6, 2009 -- Flu fears is the type of challenge that...room, according to Dr. David Benton, business grow...s growth system – The Rfactor Intensive . ...
(Date:11/25/2009)...VILLE, Calif., Nov. 25 ... announced that the company will host two investor... December 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ...resentations surrounding carfilzomib in relapsed a...the 51st American Society of Hematology (ASH) Annu...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...TY, Mo., Dec. 17 The Missouri Behavioral,Pharmacy... Substance Abuse and,Mental Health Services Admini...ous 2008 Science and Service Awards. These awards..."(1). , The program is a partnership between...
...y Baxter, et al. released this week and scheduled ...nnals of Internal Medicine , concluded that while ...ths from colorectal cancer, the association is pri...fies a possible weakness: detecting polyps on the...
...r of physicians with board certification in emerge...s of U.S. emergency departments in the foreseeable...arch team based at Massachusetts General Hospital ...ertified emergency physicians does not appear to b...
...Iowa, Dec. 17 Protocol Driven Healthcare, Inc. (P...ation products (HIP) have been awarded certificati...ce (NCQA), an independent nonprofit organization t... ConXus Steps consumer health tools (wellness pr...
... Fla., Dec. 17 SantaFe Senior Living announced,to...effective January 1, 2009.,Hart, who serves as San...Strategy and Development, will focus on the growth...of services in housing,healthcare and other progra...
..., MD, (Dec. 17, 2008)The Henry M. Jackson Foundati...(HJF) has entered into a Cooperative Research and ...ervices University of the Health Sciences (USU) an...ious Disease Clinical Research Program will work w...
Other Medicine News:Health News:Missouri Behavioral Pharmacy Management Program Receives 2008 SAMHSA Science and Service Award 2Health News:Missouri Behavioral Pharmacy Management Program Receives 2008 SAMHSA Science and Service Award 3Health News:Annals colonoscopy study underscores importance of quality standards 2Health News:Supply of board-certified emergency physicians unlikely to meet projected needs 2Health News:PDHI's Health Risk Appraisal and Consumer Health Tools Awarded NCQA HIP Certification 2Health News:SantaFe Senior Living Announces Leadership Transition 2Health News:SantaFe Senior Living Announces Leadership Transition 3Health News:HJF enters cooperative agreement to develop vaccine for staph infections 2
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: